Roche to take over Genentech for $47 billion
(AP)
<p><img src="http://d.yimg.com/img.news.yahoo.com/util/anysize/130,http%3A%2F%2Fd.yimg.com%2Fa%2Fp%2Frids%2F20090310%2Fi%2Fr727144958.jpg?v=2" align="left" height="90" width="130" alt="Severin Schwan, CEO of the Swiss pharmaceutical company Roche, attends the company's general annual shareholders meeting in Basel March 10, 2009.Swiss drugmaker Roche reiterated its $93 per share offer for U.S. biotech group Genentech was fair on Tuesday, even after a source said the two sides were in talks for a deal at a higher price. Roche also said it had started 2009 well, with operating
profit growth better than expected, and and was very confident about the outlook for the full year.
REUTERS/Michael Buholzer (SWITZERLAND)" border="0" /> (http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/ap/20090312/ap_on_bi_ge/eu_switzerland_roche_genentech)AP - Swiss pharmaceutical giant Roche said Thursday it has agreed to buy California-based Genentech for $46.8 billion in a takeover described as the largest in Swiss corporate history.</p><br clear="all"/>
http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/ap/20090312/ap_on_bi_ge/eu_switzerland_roche_genentech